Drug Database
Back to search

United States· US:23155-216_963405a6-8cd9-4d70-9de9-2afc6eab1488

CIDOFOVIR DIHYDRATE

A cidofovir product containing cidofovir, registered in United States by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.. The same ATC class is registered in 15 of our 19 countries.

ATC J05AB12US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedCIDOFOVIR DIHYDRATEATCJ05AB12REGISTER NO.US:23155-216_963405a6…PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about cidofovirAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Cidofovir is registered in 15 of 19 countries.

Countries holding a registration under ATC J05AB12 (cidofovir), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 9 of them publish a price we can compare per daily dose
Search cidofovir products by name

Cidofovir · ATC J05AB12

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
CIDOFOVIR
Manufacturer
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Country
United States (US)
ATC code
J05AB12
ATC class
Cidofovir
Defined daily dose
25 mg, P
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    2315521631
    5 mL in 1 VIAL, GLASS (23155-216-31)
  • ndc11
    23155-216-31

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

70 interactions on record for cidofovir.

Graded by severity as the source publishes them — 59 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check cidofovir against other medicinesHow interaction checks work

Cidofovir · interactions on record

70 records

  • 59 severe
  • 11 moderate

Most severe, free to view

  • NeomycinA07AA01severe
  • StreptomycinA07AA04severe
  • Polymyxin BA07AA05severe
  • Amphotericin BA07AA07severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cidofovir in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cidofovir products

Authorised across Europe · EMA

The same active substance is authorised in 17 EEA countries. Names it is sold under:

  • Austria · Cidofovir Tillomed
  • Belgium · Cidofovir Tillomed
  • Czechia · Cidofovir Tillomed
  • Germany · Cidofovir Tillomed
  • Denmark · Cidofovir Macure
  • Spain · Cidofovir Zentiva
  • Finland · Cidofovir Macure
  • France · Cidofovir Tillomed
  • United Kingdom (Northern Ireland) · Cidofovir Tillomed
  • Greece · Cidofovir Tillomed
  • Ireland · Cidofovir Tillomed
  • Italy · Cidofovir Tillomed
  • Netherlands · Cidofovir Tillomed
  • Norway · Cidofovir Macure
  • Poland · Cidofovir Tillomed
  • Portugal · Cidofovir Tillomed
  • Sweden · Cidofovir Macure

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e0c2d1e3-0221-4a0f-9ce0-b5f4738db3ff
GET /v1/drugs/e0c2d1e3-0221-4a0f-9ce0-b5f4738db3ff?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "source": "ndc",
  "strength": "375",
  "substance": "CIDOFOVIR",
  "productndc": "23155-216",
  "dosage_form": "INJECTION, SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mg/5mL",
  "application_number": "ANDA202501",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about cidofovir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console